Accessibility Menu
 
Eurofins Scientific Se logo

Eurofins Scientific Se

(OTC) ERFSF

Current Price$70.95
Market Cap$12.10B
Since IPO (2004)+355%
5 Year-22%
1 Year+11%
1 Month-6%

Eurofins Scientific Se Financials at a Glance

Market Cap

$12.10B

Revenue (TTM)

$14.25B

Net Income (TTM)

$881.31M

EPS (TTM)

$2.87

P/E Ratio

23.81

Dividend

$0.84

Beta (Volatility)

0.56 (Low)

Price

$70.95

Volume

1,000

Open

$68.28

Previous Close

$70.95

Daily Range

$67.85 - $71.37

52-Week Range

$60.09 - $86.20

ERFSF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Eurofins Scientific Se

Industry

Life Sciences Tools and Services

Employees

65,694

CEO

Gilles G. Martin, PhD

Headquarters

Luxembourg City, 1526, LU

ERFSF Financials

Key Financial Metrics (TTM)

Gross Margin

16%

Operating Margin

16%

Net Income Margin

7%

Return on Equity

12%

Return on Capital

13%

Return on Assets

4%

Earnings Yield

4.20%

Dividend Yield

1.19%

Payout Ratio

12.23%

Stock Overview

Market Cap

$12.10B

Shares Outstanding

170.53M

Volume

1.00K

Avg. Volume

4.48K

Financials (TTM)

Gross Profit

$792.70M

Operating Income

$792.70M

EBITDA

$1.45B

Operating Cash Flow

$1.29B

Capital Expenditure

$759.72M

Free Cash Flow

$534.80M

Cash & ST Invst.

$790.70M

Total Debt

$5.43B

Eurofins Scientific Se Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$3.68B

+11.4%

Gross Profit

$384.96M

-65.3%

Gross Margin

10.45%

N/A

Market Cap

$12.10B

N/A

Market Cap/Employee

$192.98K

N/A

Employees

62,696

N/A

Net Income

$228.31M

+43.8%

EBITDA

$630.96M

+13.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$4.64B

-71.8%

Accounts Receivable

$1.54B

+11.3%

Inventory

$138.95M

-0.0%

Long Term Debt

$4.70B

+41.4%

Short Term Debt

$726.73M

+20.9%

Return on Assets

4.32%

N/A

Return on Invested Capital

13.32%

N/A

Free Cash Flow

$250.81M

-26.2%

Operating Cash Flow

$789.30M

+25.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CHJTFCSPC Pharmaceutical Group Limited
$1.05+2.94%
CSPCYCSPC Pharmaceutical Group Limited
$4.30+1.11%
FSPKFFisher & Paykel Healthcare Corporation Limited
$23.02+0.00%
BMXMFbioMérieux S.A.
$82.75+0.36%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
SOFISoFi Technologies
$16.43+0.02%
SOUNSoundHound AI
$9.56+0.20%

Questions About ERFSF

What is the current price of Eurofins Scientific Se?

Eurofins Scientific Se is trading at $70.95 per share.

What is the 52-week range for Eurofins Scientific Se?

Over the past 52 weeks, Eurofins Scientific Se has traded between $60.09 and $86.20.

How much debt does Eurofins Scientific Se have?

As of the most recent reporting period, Eurofins Scientific Se reported total debt of $6.38B.

How much cash does Eurofins Scientific Se have on hand?

Eurofins Scientific Se reported $929.22M in cash and cash equivalents in its most recent financial results.

What is Eurofins Scientific Se’s dividend yield?

Eurofins Scientific Se currently has a dividend yield of 1.19%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.